Skip to content

13F-HR filed by Bain Capital Investors LLC

Bain Capital Investors LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 6 holding rows worth $8,479,874,000.

Accession
0000950123-21-015533
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 6 entries on the cover page, a total value of $8,479,874,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $8,479,874,000 with VALUE read as thousands by filing date, 13F file number 028-11185. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerBain Capital Partners X, L.P. 028-15506
  • included managerBain Capital Fund X, L.P. 028-15509
  • included managerBain Capital Integral Investors 2008, L.P. 028-15576
  • included managerBain Capital Partners Europe III, L.P. 028-16250
  • included managerBain Capital Europe Fund III, L.P. 028-16251
  • included managerBain Capital Integral Investors 2006, LLC 028-14482
  • included managerAtalaya Luxco S.a.r.l. 028-16793
  • included managerAtalaya Luxco Topco S.C.A. 028-16798
  • included managerAtalaya PIKco S.a r.l. 028-16792
  • included managerAtalaya Luxco PIKco S.C.A 028-16750
  • included managerBCPE Seminole GP LLC 028-18474
  • included managerBCPE Seminole Holdings LP 028-18475
  • included managerBain Capital Partners XII, LLC 028-20812
  • included managerBain Capital Fund XII, LP 028-20813
  • included managerBCPE Perception GP, LLC 028-20811
  • included managerBC Perception Holdings, LP 028-20815

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIVERSEY HLDGS LTDG28923103COM236,350,134$3,791,056,000thousands by filing date
SURGERY PARTNERS INC86881A100COM49,064,576$2,077,394,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U128COM60,632,356$1,788,655,000thousands by filing date
AVEANNA HEALTHCARE HLDGS INC05356F105COM81,029,675$649,858,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock617,484$147,912,000thousands by filing date
ADVANTAGE SOLUTIONS INC.00791N102COM CL A2,890,000$24,999,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-015533this filing2021-11-15acceptance time not in the bulk data set